Kyndryl wins Texas state contract for government IT services

Kyndryl (NYSE: KD) announced it received a contract from the Texas Department of Information Resources to provide deliverables-based IT services to state and local government agencies and other eligible public sector organizations.

The contract, designated DIR-CPO-6161, allows Texas public sector organizations to access Kyndryl's technology services through the Texas DIR Cooperative Contracts Program. The services include security and resiliency, cloud, applications, data and artificial intelligence capabilities.

Kyndryl's government work is led by its Kyndryl Consult advisory teams, which assess current environments, identify modernization priorities and manage multi-phase transformation efforts. The company supports agencies in strengthening cybersecurity, modernizing legacy platforms and enhancing digital service delivery while maintaining regulatory compliance.

"Kyndryl is committed to supporting the agencies that millions of Texans depend on every day," said Anita Mikus, vice president and managing director for U.S. state and local government at Kyndryl. She noted the company's experience supporting government systems and expertise across security, cloud, applications and data.

The services target public sector organizations modernizing legacy systems, addressing technical debt and strengthening cybersecurity while integrating AI adoption approaches. Kyndryl experts can assist with digital services for health and human services, transportation, courts, public safety and licensing.

Kyndryl describes itself as a provider of mission-critical enterprise technology services, offering advisory, implementation and managed service capabilities to customers in more than 60 countries. The Texas Department of Information Resources leads the state's technology strategy and protects state technology infrastructure.

You May Also Be Interested In

• Kyndryl and AWS expand partnership to scale agentic AI for enterprises
• U.S. Bank hires Eric Levine to head healthcare payments unit
• Haisco licenses two drug candidates to Nuvectis for up to $1.46B